Petra M. Makinen
Kuopio, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Non-microglial downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease-related hallmarks.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
Intracerebroventricular phospho-tau immunotherapy alleviates cortical phospho-tau burden and motor phenotype in a neuron-specific P301S tauopathy mouse.
Journal: Experimental neurology
Published: January 27, 2025
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 13, 2024
The protective PLCγ2-P522R variant mitigates Alzheimer's disease-associated pathologies by enhancing beneficial microglial functions.
Journal: Journal of neuroinflammation
Published: November 21, 2024
Monoallelic TYROBP deletion is a novel risk factor for Alzheimer's disease.
Journal: Molecular neurodegeneration
Published: May 16, 2024
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 20, 2024
Organotypic Hippocampal Slice Cultures from Adult Tauopathy Mice and Theragnostic Evaluation of Nanomaterial Phospho-TAU Antibody-Conjugates.
Journal: Cells
Published: April 21, 2023
Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.
Journal: Neurobiology of disease
Published: February 23, 2023
S327 phosphorylation of the presynaptic protein SEPTIN5 increases in the early stages of neurofibrillary pathology and alters the functionality of SEPTIN5.
Journal: Neurobiology of disease
Published: September 10, 2021
Last Updated: 09/26/2026